Original Article| Volume 24, ISSUE 8, P1938-1947, August 2015

Early Dynamics of P-selectin and Interleukin 6 Predicts Outcomes in Ischemic Stroke


      Thromboinflammatory molecules connect the prothrombotic state, endothelial dysfunction, and systemic/local inflammation in the acute phase of ischemic stroke.


      We prospectively investigated (1) serial changes in the levels of thromboinflammatory biomarkers in 76 patients with acute ischemic stroke (6, 24, and 72 hours after onset); (2) compared with 44 patients with asymptomatic severe (≥70%) carotid stenosis and 66 patients with Parkinson disease; and (3) we applied multiple regression methods, relating biological biomarkers combined with demographic data and comorbidities to poststroke infection, death, and functional outcome, and assessed the ability of the models to predict each outcome.


      Interleukin 6 (IL-6) levels and change of IL-6 concentrations by 72 hours correlated with the size of tissue damage indicated by S100B titers. Levels of IL-6 and P-selectin at 72 hours were higher in patients with large-artery versus lacunar stroke. High concentration of IL-6, monocyte chemotactic protein 1, and S100B at 6 hours were associated with poststroke infections; high concentration of IL-6, S100B, and high-sensitivity C-reactive protein (hsCRP) correlated with death. Change of P-selectin from 6 to 72 hours by 1 unit increased the incidence of poststroke infections with an odds ratio of 22.7; each 100 units of IL-6 at baseline increased the odds of death by 9‰, and at 72 hours, the odds of poststroke infections by 4‰. Each unit of baseline hsCRP elevated the odds of death by 7%.


      In regression models, in which biological, demographic, and comorbid factors were combined, those biological biomarkers predicted poor outcome with high accuracy, which were characterized by an increasing concentration by 72 hours. Two particular biomarkers emerged to predict outcomes besides hsCRP: early dynamic changes in the systemic levels of P-selectin and IL-6.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Magnus T.
        • Wiendl H.
        • Kleinschnitz C.
        Immune mechanisms of stroke.
        Curr Opin Neurol. 2012; 25: 334-340
        • Kim J.Y.
        • Kawabori M.
        • Yenari M.A.
        Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets.
        Curr Med Chem. 2014; 21: 2076-2097
        • Vogelgesang A.
        • May V.E.
        • Grunwald U.
        • et al.
        Functional status of peripheral blood T-cells in ischemic stroke patients.
        PLoS One. 2010; 5: e8718
        • Molnar T.
        • Peterfalvi A.
        • Szereday L.
        • et al.
        Deficient leucocyte antisedimentation is related to post-stroke infections and outcome.
        Clin Pathol. 2008; 61: 1209-1213
        • Peterfalvi A.
        • Molnar T.
        • Banati M.
        • et al.
        Impaired function of innate T lymphocytes and NK cells in the acute phase of ischemic stroke.
        Cerebrovasc Dis. 2009; 28: 490-498
        • Habets K.L.
        • Huizinga T.W.
        • Toes R.E.
        Platelets and autoimmunity.
        Eur J Clin Invest. 2013; 43: 746-757
        • Qu Z.
        • Chaikof E.L.
        Interface between hemostasis and adaptive immunity.
        Curr Opin Immunol. 2010; 22: 634-642
        • Ortolano S.
        • Spuch C.
        tPA in the central nervous system: relations between tPA and cell surface LRPs.
        Recent Pat Endocr Metab Immune Drug Discov. 2013; 7: 65-76
        • Smyth S.S.
        • McEver R.P.
        • Weyrich A.S.
        • et al.
        Platelet functions beyond hemostasis.
        J Thromb Haemost. 2009; 7: 1759-1766
        • Weyrich A.S.
        • Elstad M.R.
        • McEver R.P.
        • et al.
        Activated platelets signal chemokine synthesis by human monocytes.
        J Clin Invest. 1996; 97: 1525-1534
        • Christersson C.
        • Johnell M.
        • Siegbahn A.
        Tissue factor and IL8 production by P-selectin-dependent platelet-monocyte aggregates in whole blood involves phosphorylation of Lyn and is inhibited by IL10.
        J Thromb Haemost. 2008; 6: 986-994
        • Henn V.
        • Slupsky J.R.
        • Gräfe M.
        • et al.
        CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells.
        Nature. 1998; 391: 591-594
        • Sprague D.L.
        • Elzey B.D.
        • Crist S.A.
        • et al.
        Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles.
        Blood. 2008; 111: 5028-5036
        • Yadav A.
        • Saini V.
        • Arora S.
        MCP-1: chemoattractant with a role beyond immunity: a review.
        Clin Chim Acta. 2010; 411: 1570-1579
        • Lambertsen K.L.
        • Biber K.
        • Finsen B.
        Inflammatory cytokines in experimental and human stroke.
        J Cereb Blood Flow Metab. 2012; 32: 1677-1698
        • Suzuki S.
        • Tanaka K.
        • Suzuki N.
        Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects.
        J Cereb Blood Flow Metab. 2009; 29: 464-479
        • Tarkowski E.
        • Rosengren L.
        • Blomstrand C.
        • et al.
        Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke.
        Stroke. 1995; 26: 1393-1398
        • Acalovschi D.
        • Wiest T.
        • Hartmann M.
        • et al.
        Multiple levels of regulation of the interleukin-6 system in stroke.
        Stroke. 2003; 34: 1864-1869
      1. Agrawal A, Gang TB, Rusiñol AE. Recognition functions of pentameric C-reactive protein in cardiovascular disease. DOI: 10.1155/2014/319215.

        • Széplaki G.
        • Szegedi R.
        • Hirschberg K.
        • et al.
        Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes.
        Atherosclerosis. 2009; 204: 315-320
      2. Westendorp WF, Nederkoorn PJ, Vermeij JD, et al. Post-stroke infection: a systematic review and meta-analysis. BMC Neurol DOI: 10.1186/1471-2377-11-110.

        • Katzan I.L.
        • Cebul R.D.
        • Husak S.H.
        • et al.
        The effect of pneumonia on mortality among patients hospitalized for acute stroke.
        Neurology. 2003; 60: 620-625
        • Deleidi M.
        • Gasser T.
        The role of inflammation in sporadic and familial Parkinson's disease.
        Cell Mol Life Sci. 2013; 70: 4259-4273
        • Worthmann H.
        • Tryc A.B.
        • Goldbecker A.
        • et al.
        The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome.
        Cerebrovasc Dis. 2010; 30: 85-92
        • Herrmann M.
        • Vos P.
        • Wunderlich M.T.
        • et al.
        Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100 and glial fibrillary acidic protein.
        Stroke. 2000; 31: 2670-2677
        • AbuRahma A.F.
        • Srivastava M.
        • Stone P.A.
        • et al.
        Critical appraisal of the Carotid Duplex Consensus criteria in the diagnosis of carotid artery stenosis.
        J Vasc Surg. 2011; 53: 53-59
        • Cohen J.
        • Brun-Bruisson C.
        • Torres A.
        • et al.
        Diagnosis of infection in sepsis: an evidence-based review.
        Crit Care Med. 2004; 32: 466-494
        • Molnar T.
        • Pusch G.
        • Papp V.
        • et al.
        The L-arginine pathway in acute ischemic stroke and severe carotid stenosis: temporal profiles and association with biomarkers and outcome.
        J Stroke Cerebrovasc Dis. 2014; 23: 2206-2214
        • Heinze G.
        • Schemper M.
        A solution to the problem of separation in logistic regression.
        Stat Med. 2002; 21: 2409-2419
        • Garlichs C.D.
        • Kozina S.
        • Fateh-Moghadam S.
        • et al.
        Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia.
        Stroke. 2003; 34: 1412-1418
        • Ormstad H.
        • Aass H.C.
        • Lund-Sørensen N.
        • et al.
        Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume.
        J Neurol. 2011; 258: 677-685
        • Hasan N.
        • McColgan P.
        • Bentley P.
        • et al.
        Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review.
        Br J Clin Pharmacol. 2012; 74: 230-240
        • Thakore A.H.
        • Guo C.Y.
        • Larson M.G.
        • et al.
        Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study).
        Am J Cardiol. 2007; 99: 1598-1602
        • Novo S.
        • Basili S.
        • Tantillo R.
        • et al.
        Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis.
        Stroke. 2005; 36: 673-675
        • Licata G.
        • Tuttolomondo A.
        • Di Raimondo D.
        • et al.
        Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke.
        Thromb Haemost. 2009; 101: 929-937
        • Faraday N.
        • Scharpf R.B.
        • Dodd-o J.M.
        • et al.
        Leukocytes can enhance platelet-mediated aggregation and thromboxane release via interaction of P-selectin glycoprotein ligand 1 with P-selectin.
        Anesthesiology. 2001; 94: 145-151
        • Gronberg N.V.
        • Johansen F.F.
        • Kristiansen U.
        • et al.
        Leukocyte infiltration in experimental stroke.
        J Neuroinflammation. 2013; 10: 115
        • Lukasik M.
        • Dworacki G.
        • Kufel-Grabowska J.
        • et al.
        Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke.
        Thromb Haemost. 2012; 107: 346-355
        • Blum A.
        • Vaispapir V.
        • Keinan-Boker L.
        • et al.
        Endothelial dysfunction and procoagulant activity in acute ischemic stroke.
        J Vasc Interv Neurol. 2012; 5: 33-39
        • Erta M.
        • Quintana A.
        • Hidalgo J.
        Interleukin-6, a major cytokine in the central nervous system.
        Int J Biol Sci. 2012; 8: 1254-1266
        • Smith C.J.
        • Emsley H.C.
        • Gavin C.M.
        • et al.
        Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome.
        BMC Neurol. 2004; 4: 2
        • Tezono K.
        • Sarker K.P.
        • Kikuchi H.
        • et al.
        Bioactivity of the vascular endothelial growth factor trapped in fibrin clots: production of IL-6 and IL-8 in monocytes by fibrin clots.
        Haemostasis. 2001; 31: 71-79
        • Hug A.
        • Dalpke A.
        • Wieczorek N.
        • et al.
        Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection.
        Stroke. 2009; 40: 3226-3232